Dmitry Balyasny’s Globus Medical GMED Stock Holding History

Dmitry Balyasny’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-150,000	Closed	-$7.43M	–	1474
2020 Q3	$7.43M	Buy	+150,000	New	+$7.74M	0.05%	480

Other funds holding GMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Dmitry Balyasny's GMED Position: Q2 2026 in Review

Dmitry Balyasny sold out of Globus Medical (GMED) in Q2 2026, closing a stake of 63,487 shares — an estimated $5.47M sold.

Dmitry Balyasny first reported a position in GMED in Q2 2013 and held it in 22 quarters. The position peaked at $32.8M in Q1 2022. 593 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

Dmitry Balyasny reported no remaining Globus Medical position as of Q2 2026 after selling out during the quarter.
Dmitry Balyasny sold 63,487 Globus Medical shares in Q2 2026, an estimated $5.47M.
Dmitry Balyasny first reported a position in Globus Medical in Q2 2013 and held it in 22 quarters.
Dmitry Balyasny's Globus Medical position peaked at $32.8M in Q1 2022.
593 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.